Dysplasia detection rate of confirmatory EGD in nondysplastic Barrett's esophagus

Diseases of the Esophagus

Volumn 27, Issue 6, 2014, Pages 505-510

  Abdalla, M ^a   Dhanekula, R ^b   Greenspan, M ^b   Mobarhan, S ^b   Patil, A ^b   Jakate, S ^c   Giusto, D ^c   Silva, R ^a   Li, H ^b   Melson, J ^b  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c Path Pathology Services   (United States)

Author keywords

Barrett's esophagus; High grade dysplasia; Long segment Barrett's esophagus; Low grade dysplasia; Short segment Barrett's esophagus

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; COHORT ANALYSIS; DYSPLASIA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; BIOPSY; ESOPHAGOSCOPY; ESOPHAGUS; HEALTH SURVEY; MIDDLE AGED; PATHOLOGY; PRECANCER;

AGED; BARRETT ESOPHAGUS; BIOPSY; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRECANCEROUS CONDITIONS;

EID: 84905025091     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2012.01431.x     Document Type: Article

References (25)

1. Wang K K, Sampliner R E, Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 788-797.
2. Garud S S, Keilin S, Cai Q, Willingham F F. Diagnosis and management of Barrett's esophagus for the endoscopist. Therap Adv Gastroenterol. 2010; 3: 227-238.
3. Phillips W A, Lord R V, Nancarrow D J, Watson D I, Whiteman D C. Barrett's esophagus. J Gastroenterol Hepatol 2011; 26: 639-648.
4. Sharma P. Clinical practice. Barrett's esophagus. N Engl J Med 2009; 361: 2548-2556.
5. Hvid-Jensen F, Pedersen L, Drewes A M, Sorensen H T, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-1383.
6. Sharma P, Falk G W, Weston A P, Reker D, Johnston M, Sampliner R E. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006; 4: 566-572.
7. Schnell T G, Sontag S J, Chejfec G etal. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-1619.
8. Weston A P, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A. Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 2000; 95: 1888-1893.
9. Hirota W K, Zuckerman M J, Adler D G etal. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006; 63: 570-580.
10. Sharma P, McQuaid K, Dent J etal. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 2004; 127 (1): 310-330.
11. Iftikhar S Y, James P D, Steele R J, Hardcastle J D, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992; 33: 1155-1158.
12. Weston A P, Badr A S, Hassanein R S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999; 94: 3413-3419.
13. Hirota W K, Loughney T M, Lazas D J, Maydonovitch C L, Rholl V, Wong R K. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-285.
14. Gopal D V, Lieberman D A, Magaret N etal. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci 2003; 48: 1537-1541.
15. Prasad G A, Bansal A, Sharma P, Wang K K. Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am J Gastroenterol 2010; 105: 1490-1502.
16. Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer 2007; 109: 668-674.
17. Ajumobi A, Bahjri K, Jackson C, Griffin R. Surveillance in Barrett's esophagus: an audit of practice. Dig Dis Sci 2010; 55: 1615-1621.
18. Bright T, Schloithe A, Bull J A, Fraser R J, Bampton P, Watson D I. Outcome of endoscopy surveillance for Barrett's oesophagus. ANZ J Surg 2009; 79: 812-816.
19. El-Serag H B, Naik A D. Surveillance in Barrett's esophagus: lessons from behavioral economics. Gastroenterology 2009; 137: 763-765.
20. Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess 2006; 10:11-14.
21. Somerville M, Garside R, Pitt M, Stein K. Surveillance of Barrett's oesophagus: is it worthwhile? Eur J Cancer 2008; 44: 588-599.
22. Inadomi J M, Sampliner R, Lagergren J, Lieberman D, Fendrick A M, Vakil N. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med 2003; 138: 176-186.
23. Kelty C J, Goucj M D, Van Wyk Q, Steohenson T J, Ackroyd R. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroentrol 2007; 42: 1271-1274.
24. Chandrasoma P, Wijetunge S, DeMeester S etal. Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenocarcinoma. Am J Surg Pathol 2012; 36 (1): 1-7.
25. Spechler S J, Sharma P, Souza R F etal. American Gastroenterological Association Medical Position Statement on the management of Barrett's esophagus. Gastroenterology 2011; 140: 1084-1091.